Details for Patent: 10,493,035
✉ Email this page to a colleague
Which drugs does patent 10,493,035 protect, and when does it expire?
Patent 10,493,035 protects OXBRYTA and is included in one NDA.
This patent has twelve patent family members in eight countries.
Summary for Patent: 10,493,035
| Title: | Tablets comprising 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzald- ehyde |
| Abstract: | Provided herein are high strength/high drug load tablets comprising 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzald- ehyde ("Compound 1"), dispersible tablets comprising Compound 1, processes of manufacturing such tablets, and methods for treating patients with the tablets. Compound 1 is useful for treating hematological disorders such as sickle cell disease, pulmonary disease such as idiopathic pulmonary fibrosis, and hypoxia and hypoxemia conditions. |
| Inventor(s): | Dalziel; Sean Mark (Burlingame, CA), Bejugam; Naveen (Santa Clara, CA), Habibizad; Nazila (San Mateo, CA), Komeyli; Ali (Pacifica, CA), Leung; DeMei (Los Altos, CA) |
| Assignee: | Global Blood Therapeutics, Inc. (South San Francisco, CA) |
| Application Number: | 15/782,381 |
|
Patent Claim Types: see list of patent claims | Compound; Dosage form; |
Drugs Protected by US Patent 10,493,035
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Global Blood Theraps | OXBRYTA | voxelotor | TABLET;ORAL | 213137-002 | Oct 14, 2022 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| Global Blood Theraps | OXBRYTA | voxelotor | TABLET;ORAL | 213137-001 | Nov 25, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,493,035
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 110638 | ⤷ Sign Up | |||
| Brazil | 112019006506 | ⤷ Sign Up | |||
| European Patent Office | 3525766 | ⤷ Sign Up | |||
| Israel | 265777 | ⤷ Sign Up | |||
| Israel | 296014 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
